信号转导和转录激活因子3（STAT3）及信号转导和转录激活因子5b（STAT5b）基因多态性与乳腺癌风险及临床预后相关。
STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.
作者信息
Zhao Ling, Zhang Qingyuan, Luan Xin, Huang Xu, Zhao Shu, Zhao Hong
机构信息
Department of Medical Oncology, The Tumor Hospital of Harbin Medical University Harbin 150040, China.
出版信息
Int J Clin Exp Pathol. 2015 Feb 1;8(2):2033-8. eCollection 2015.
Abstract
We conducted a case-control study in a Chinese population, and investigated the role of STAT3 rs4796793 and STAT5b rs6503691 polymorphisms in the risk and clinical outcome of breast cancer. STAT5b rs6503691 polymorphisms and STAT3 rs4796793 polymorphisms were genotyped by TaqMan SNP Genotyping Assays on the ABI 7500 fast real-time PCR platform. Unconditional logistic regression analyses showed that subjects carrying the GG genotype of STAT3 rs4796793 had a significantly increased risk of breast cancer, with an adjusted OR (95% CI) of 0.35 (0.12-0.95). In the Cox proportional hazards model, we observed that individuals carrying CG+GG genotype of STAT3 rs4796793 was associated with reduced risk of death from breast cancer when compared with CC genotype (HR = 0.43, 95% CI = 0.20-0.93). Our study found that STAT3 rs4796793 polymorphism plays an important role in influence the development and overall survival of breast cancer patients.
摘要
我们在中国人群中开展了一项病例对照研究，调查信号转导和转录激活因子3（STAT3）rs4796793及信号转导和转录激活因子5b（STAT5b）rs6503691基因多态性在乳腺癌风险及临床结局中的作用。采用TaqMan SNP基因分型检测法在ABI 7500快速实时聚合酶链反应（PCR）平台上对STAT5b rs6503691基因多态性和STAT3 rs4796793基因多态性进行基因分型。非条件逻辑回归分析显示，携带STAT3 rs4796793基因GG基因型的受试者患乳腺癌风险显著增加，校正比值比（OR）（95%置信区间）为0.35（0.12 - 0.95）。在Cox比例风险模型中，我们观察到，与CC基因型相比，携带STAT3 rs4796793基因CG + GG基因型的个体乳腺癌死亡风险降低（风险比 = 0.43，95%置信区间 = 0.20 - 0.93）。我们的研究发现，STAT3 rs4796793基因多态性在影响乳腺癌患者的疾病发展及总生存方面发挥重要作用。
相似文献
1
STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.信号转导和转录激活因子3（STAT3）及信号转导和转录激活因子5b（STAT5b）基因多态性与乳腺癌风险及临床预后相关。
Int J Clin Exp Pathol. 2015 Feb 1;8(2):2033-8. eCollection 2015.
2
STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes.信号转导和转录激活因子3（STAT3）基因变异，单独或与信号转导和转录激活因子5b（STAT5b）基因多态性共同作用，会影响乳腺癌风险及临床预后。
Med Oncol. 2015 Jan;32(1):375. doi: 10.1007/s12032-014-0375-z. Epub 2014 Dec 7.
3
Association of signal transducer and activator of transcription 3 gene polymorphisms with cervical cancer in Chinese women.信号转导子和转录激活子 3 基因多态性与中国女性宫颈癌的关联。
DNA Cell Biol. 2011 Nov;30(11):931-6. doi: 10.1089/dna.2010.1179. Epub 2011 Jun 13.
4
STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland.STAT3 多态性和 IL-6 多态性与波兰北部患者基底细胞癌的风险相关。
Arch Dermatol Res. 2019 Nov;311(9):697-704. doi: 10.1007/s00403-019-01952-7. Epub 2019 Jul 24.
5
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.STAT3 rs4796793 与肺癌风险及铂类化疗的临床结局相关。
Int J Clin Oncol. 2019 May;24(5):476-484. doi: 10.1007/s10147-018-01386-7. Epub 2019 Jan 28.
6
Association between polymorphisms in the signal transducer and activator of transcription and dilated cardiomyopathy in the Chinese Han population.信号转导和转录激活因子与中国人扩张型心肌病的相关性研究。
Mol Cell Biochem. 2012 Jan;360(1-2):197-203. doi: 10.1007/s11010-011-1057-1. Epub 2011 Sep 23.
7
STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population.信号转导和转录激活因子3（STAT3）基因多态性rs4796793可能是日本人群转移性肾细胞癌中肿瘤对多种酪氨酸激酶抑制剂反应的预测因素。
Med Oncol. 2016 Mar;33(3):24. doi: 10.1007/s12032-016-0733-0. Epub 2016 Jan 30.
8
A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population.APE1 基因启动子中的遗传变异（-656T>G）与中国人群的乳腺癌风险和进展相关。
Gene. 2013 Nov 15;531(1):97-100. doi: 10.1016/j.gene.2013.08.052. Epub 2013 Aug 28.
9
STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer.信号转导与转录激活因子3（STAT3）基因多态性与非小细胞肺癌易感性
Genet Mol Res. 2011 Aug 26;10(3):1856-65. doi: 10.4238/vol10-3gmr1071.
10
Signal transducers and activators of transcription (STATs) gene polymorphisms related with susceptibility to rheumatic heart disease in north Indian population.与印度北部人群风湿性心脏病易感性相关的信号转导子和转录激活子（STATs）基因多态性
Immunol Lett. 2014 Sep;161(1):100-5. doi: 10.1016/j.imlet.2014.04.015. Epub 2014 May 4.
引用本文的文献
1
Y665F variant of mouse Stat5b protects against acute kidney injury through transcriptomic shifts in renal gene expression.小鼠Stat5b的Y665F变体通过肾基因表达的转录组变化预防急性肾损伤。
Sci Rep. 2025 Aug 21;15(1):30696. doi: 10.1038/s41598-025-15812-0.
2
Y665F variant of mouse protects against acute kidney injury through transcriptomic shifts in renal gene expression.小鼠的Y665F变体通过肾脏基因表达的转录组变化预防急性肾损伤。
bioRxiv. 2025 Feb 23:2025.02.19.639141. doi: 10.1101/2025.02.19.639141.
3
Association of JAK/STAT genetic variants with cutaneous melanoma.JAK/STAT基因变异与皮肤黑色素瘤的关联。
Front Oncol. 2022 Aug 2;12:943483. doi: 10.3389/fonc.2022.943483. eCollection 2022.
4
The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility.白细胞介素-6/信号转导与转录激活因子3信号通路的多态性可能与皮肤T细胞淋巴瘤易感性有关。
Arch Dermatol Res. 2021 Jan;313(1):25-31. doi: 10.1007/s00403-020-02062-5. Epub 2020 Apr 8.
5
Determination of rs12778366, rs2981582, rs744166, and rs1800625 Single Gene Polymorphisms in Patients with Laryngeal Squamous Cell Carcinoma.喉鳞癌患者 rs12778366、rs2981582、rs744166 和 rs1800625 单核苷酸基因多态性的测定。
Dis Markers. 2019 Nov 12;2019:3907232. doi: 10.1155/2019/3907232. eCollection 2019.
6
STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland.STAT3 多态性和 IL-6 多态性与波兰北部患者基底细胞癌的风险相关。
Arch Dermatol Res. 2019 Nov;311(9):697-704. doi: 10.1007/s00403-019-01952-7. Epub 2019 Jul 24.
7
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.STAT3 rs4796793 与肺癌风险及铂类化疗的临床结局相关。
Int J Clin Oncol. 2019 May;24(5):476-484. doi: 10.1007/s10147-018-01386-7. Epub 2019 Jan 28.
8
Association of high-evidence gastric cancer susceptibility loci and somatic gene expression levels with survival.高证据胃癌易感基因座及体细胞基因表达水平与生存的关联
Carcinogenesis. 2017 Oct 26;38(11):1119-1128. doi: 10.1093/carcin/bgx090.
本文引用的文献
1
STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.在人乳腺癌的claudin低表达模型中，STAT3信号通路在肿瘤起始细胞中优先被激活。
Stem Cells. 2014 Oct;32(10):2571-82. doi: 10.1002/stem.1752.
2
Breast cancer in China.中国的乳腺癌。
Lancet Oncol. 2014 Jun;15(7):e279-89. doi: 10.1016/S1470-2045(13)70567-9.
3
rs744166 polymorphism of the STAT3 gene is associated with risk of gastric cancer in a Chinese population.信号转导与转录激活因子3（STAT3）基因的rs744166多态性与中国人群患胃癌的风险相关。
Biomed Res Int. 2014;2014:527918. doi: 10.1155/2014/527918. Epub 2014 Apr 23.
4
Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.靶向癌症中的信号转导与转录激活因子3（STAT3）信号通路：合成抑制剂与天然抑制剂的作用
Biochim Biophys Acta. 2014 Apr;1845(2):136-54. doi: 10.1016/j.bbcan.2013.12.005. Epub 2014 Jan 2.
5
STAT3 rs3816769 polymorphism correlates with gene expression level and may predispose to nonsmall cell lung cancer: a preliminary study.STAT3基因rs3816769多态性与基因表达水平相关，可能易患非小细胞肺癌：一项初步研究。
Pol Arch Med Wewn. 2013;123(12):672-9. doi: 10.20452/pamw.2009.
6
Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma.JAK/STAT 信号通路基因多态性与非霍奇金淋巴瘤风险。
Leuk Res. 2013 Sep;37(9):1120-4. doi: 10.1016/j.leukres.2013.05.003. Epub 2013 Jun 12.
7
STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer.STAT3，一个不良生存预测因子，与乳腺癌淋巴结转移相关。
J Breast Cancer. 2013 Mar;16(1):40-9. doi: 10.4048/jbc.2013.16.1.40. Epub 2013 Mar 31.
8
Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance.分子通路：Jak/STAT 通路：突变、抑制剂和耐药性。
Clin Cancer Res. 2013 Apr 15;19(8):1933-40. doi: 10.1158/1078-0432.CCR-12-0284. Epub 2013 Feb 13.
9
Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.信号转导和转录激活因子 3 多态性与肝癌中乙型肝炎病毒突变的相互作用。
Hepatology. 2013 Jun;57(6):2369-77. doi: 10.1002/hep.26303.
10
STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma.STAT3 多态性可预测转移性肾细胞癌患者对干扰素-α治疗的反应。
Eur Urol. 2013 Apr;63(4):745-52. doi: 10.1016/j.eururo.2012.09.052. Epub 2012 Sep 28.
Zotero 插件